Adherence to oral anticoagulation in a Belgium atrial fibrillation population measured by a medical event monitoring system

4 April 2022 (13:32 - 13:40)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Miss Lieselotte Knaepen

Hasselt University, Hasselt (Belgium)

5 More presentations in this session

Presentation thumbnail

Left atrial thrombus in atrial fibrillation/flutter patients in relation to anticoagulation strategy: LATTEE registry

Doctor M. Gawalko (Warsaw, PL)

Abstract Slides Video

Presentation thumbnail

Detection of atrial fibrillation in patients with cryptogenic stroke: The Nordic Atrial Fibrillation and Stroke (NOR-FIB) study - topline results

Doctor B. Ratajczak-Tretel (Sarpsborg, NO)

Abstract Slides Video

Presentation thumbnail

Oral anticoagulants in older patients with atrial fibrillation: insights from a nationwide study

Doctor P. Rasmussen (Copenhagen, DK)

Abstract Slides Video

Presentation thumbnail

Effectiveness and safety of edoxaban in 27,333 patients from ETNA-AF with and without a history of intracranial haemorrhage after 2 years of treatment

Professor J. Moser (Hamburg, DE)

Abstract Slides Video

Presentation thumbnail

Systolic blood pressure and effects of screening for atrial fibrillation with long-term continuous monitoring

Mr L. Xing (Copenhagen, DK)

Abstract Slides Video

Access the full session

Session thumbnail

What is new on stroke prevention

The Event

Event poster

EHRA 2022

4 April 2022 13:32 CET

You may be interested in

Congress Session

Stroke prevention in clinical and subclinical atrial fibrillation

Congress Session

Oral anticoagulation in subclinical atrial fibrillation

Congress Presentation

Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - con

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources